NCT05386303 (HYDRO-NiP) is a clinical trial in Hydrocephalus, sponsored by Nantes University Hospital.

Who is sponsoring NCT05386303?

NCT05386303 is sponsored by Nantes University Hospital.

What condition does NCT05386303 study?

NCT05386303 studies Hydrocephalus, Critical Care.

Is NCT05386303 still recruiting?

NCT05386303 is currently status unknown. Last updated 23 May 2022.

Last reviewed 2022-05-23 · How we verify

NCT05386303: HYDRO-NiP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative Pupillometry

Status unknown Last updated 23 May 2022

What this trial tests

trial in Hydrocephalus in 60 participants. Status unknown.

Timeline

31 May 2022

Primary endpoint
1 September 2024

1 September 2024

Quick facts

Lead sponsor	Nantes University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	31 May 2022
Primary completion	1 September 2024
Estimated completion	1 September 2024
Sites	2 locations across France

Conditions studied

Hydrocephalus — all drugs for Hydrocephalus →
Critical Care — all drugs for Critical Care →

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Hydrocephalus or Critical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the diagnostic ability of quantitative pupillometry for the early detection of hydrocephalus during the weaning process of the external ventricular drain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hydrocephalus

Currently open trials in the same condition.

NCT07478926 — Flow Detection in Open and Closed Shunt Valve Periods · NA · recruiting
NCT07442929 — Crystallization of LA and Adjuvant Mixtures in Cerebrospinal Fluid · recruiting
NCT06797219 — Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4 · NA · recruiting
NCT07380477 — VentricuLostomy AssoCiaTed InfeCtions (LACTIC): Focus on CSF Lactate and Sampling Site · recruiting
NCT06276543 — Bactiseal Catheter Safety Registry Study · recruiting

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05386303 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 23 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing